Eagle Global Advisors LLC Novartis Ag Transaction History

Eagle Global Advisors LLC

$1.96 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	SELL	$80.03 - $92.81 $1.95 Million - $2.27 Million	-24,413 Reduced 87.97%	3,340 $307,000
Q4 2022 Feb 07, 2023	SELL	$75.55 - $92.52 $36,037 - $44,132	-477 Reduced 1.69%	27,753 $2.52 Million
Q3 2022 Oct 24, 2022	SELL	$74.61 - $87.26 $64,015 - $74,869	-858 Reduced 2.95%	28,230 $2.15 Million
Q2 2022 Aug 11, 2022	SELL	$80.52 - $93.75 $97,831 - $113,906	-1,215 Reduced 4.01%	29,088 $2.46 Million
Q1 2022 Apr 20, 2022	BUY	$80.11 - $90.62 $11,375 - $12,868	142 Added 0.47%	30,303 $2.66 Million
Q4 2021 Feb 01, 2022	SELL	$79.7 - $88.13 $91,495 - $101,173	-1,148 Reduced 3.67%	30,161 $2.64 Million
Q3 2021 Nov 15, 2021	SELL	$81.78 - $95.14 $17,582 - $20,455	-215 Reduced 0.68%	31,309 $2.56 Million
Q2 2021 Jul 15, 2021	BUY	$85.24 - $94.15 $61,798 - $68,258	725 Added 2.35%	31,524 $2.88 Million
Q1 2021 May 07, 2021	SELL	$83.5 - $98.47 $67,551 - $79,662	-809 Reduced 2.56%	30,799 $2.63 Million
Q4 2020 Feb 01, 2021	SELL	$78.07 - $94.43 $69,482 - $84,042	-890 Reduced 2.74%	31,608 $2.99 Million
Q3 2020 Oct 22, 2020	SELL	$82.14 - $91.0 $11,088 - $12,285	-135 Reduced 0.41%	32,498 $2.83 Million
Q2 2020 Aug 14, 2020	SELL	$80.93 - $91.1 $86,595 - $97,477	-1,070 Reduced 3.17%	32,633 $2.85 Million
Q1 2020 May 06, 2020	SELL	$70.67 - $99.01 $137,665 - $192,871	-1,948 Reduced 5.46%	33,703 $2.78 Million
Q4 2019 Feb 06, 2020	SELL	$84.35 - $95.37 $118,089 - $133,518	-1,400 Reduced 3.78%	35,651 $3.38 Million
Q3 2019 Nov 14, 2019	SELL	$85.54 - $94.26 $263,805 - $290,697	-3,084 Reduced 7.68%	37,051 $3.22 Million
Q2 2019 Aug 13, 2019	SELL	$75.4 - $92.8 $455,340 - $560,419	-6,039 Reduced 13.08%	40,135 $3.67 Million
Q1 2019 Apr 22, 2019	SELL	$75.32 - $86.15 $5,573 - $6,375	-74 Reduced 0.16%	46,174 $4.44 Million
Q4 2018 Jan 30, 2019	SELL	$73.66 - $82.02 $187,096 - $208,330	-2,540 Reduced 5.21%	46,248 $3.97 Million
Q3 2018 Nov 14, 2018	SELL	$66.94 - $77.43 $14,726 - $17,034	-220 Reduced 0.45%	48,788 $4.2 Million
Q2 2018 Aug 01, 2018	SELL	$64.91 - $73.36 $89,186 - $100,796	-1,374 Reduced 2.73%	49,008 $3.7 Million
Q1 2018 May 04, 2018	SELL	$70.39 - $84.15 $344,981 - $412,419	-4,901 Reduced 8.87%	50,382 $4.07 Million
Q4 2017 Feb 13, 2018	BUY	$72.33 - $77.64 $23,507 - $25,233	325 Added 0.59%	55,283 $4.64 Million
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $4.07 Million - $4.25 Million	54,958	54,958 $4.72 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Global Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Global Advisors LLC with notifications on news.

Account